Tailor-made Antibodies
and Tools for Life Science
quick order | cart
?
|
login
Home|||||Technical Support
Home > Products > 311 011AT647N

MLC-2A antibody - 311 011AT647N

Myosin light chain 2A or MLC-2A is specific for the atrium of the mammalian heart
Mouse monoclonal purified IgG
Cat. No.: 311 011AT647N
Amount: 100 µg
Price: $470.00
Cat. No. 311 011AT647N 100 µg purified IgG, lyophilized, fluorescence-labeled with ATTO® 647N.

For many of the fluorescence labeled antibodies conjugated to ATTO® dyes from ATTO-TEC the established fluorescence detection systems can be used.

ATTO® 488: λex 500 nm / λem 520 nm
ATTO® 550: λex 554 nm / λem 576 nm
ATTO® 565: λex 564 nm / λem 590 nm
ATTO® 594: λex 603 nm / λem 626 nm
ATTO® 647N: λex 646 nm / λem 664 nm
 

ATTO®488, ATTO®565, ATTO®647N and ATTO®594 dyes are suitable for Stimulated Emission Depletion (STED) microscopy which allows higher resolution imaging compared to confocal laser scanning microscopy.
ATTO®488, ATTO®565 and ATTO®594 are also recommended for PALM and dSTORM high resolution microscopy.

This product or portions thereof is manufactured under license from ATTO-TEC GmbH.
ATTO is a trademarks of ATTO-TEC GmbH, Siegen/Germany.
Purchase of reagents related to the AbberiorStar technology from Synaptic Systems GmbH provides a license for non-profit and in-house research use only. Any application of above mentioned technology for commercial purpose requires a separate license from ATTO-TEC GmbH.

 Albumin and azide were added for stabilization. For reconstitution add 100 µl H2O to get a 1mg/ml solution in PBS. Either add 1:1 (v/v) glycerol, then aliquot and store at -20°C until use, or store aliquots at -80°C without additives.
Reconstitute immediately upon receipt! Avoid bright light when working with the antibody to minimize photo bleeching of the fluorescent dye.
Applications
 
WB: N/A
IP: N/A
ICC: yes (see remarks)
IHC: yes
IHC-P: 1 : 200 gallery  
Label ATTO 647N
Clone 56F5
Subtype IgG2b (κ light chain)
Immunogen Full-length recombinant human MLC-2A (UniProt Id: Q01449)
Reactivity Reacts with: human (Q01449), rat, mouse (Q9QVP4).
No signal: chicken.
Other species not tested yet.
Specificity Specific for MLC-2A, no cross-reactivity to MLC-2V.
Matching control protein/peptide 311-0P
Remarks

ICC: Methanol fixation gives stronger signals.
Data sheet 311_011at647n.pdf

References for MLC-2A - 311 011AT647N

Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes.
Gao Y, Su L, Wei Y, Tan S, Hu Z, Tao Z, Kovalik JP, Soong TW, Zhang J, Pu J, Ye L, et al.
Theranostics (2023) 1311: 3872-3896. 311 011AT647N ICC, FACS; tested species: human
Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes.
Gao Y, Su L, Wei Y, Tan S, Hu Z, Tao Z, Kovalik JP, Soong TW, Zhang J, Pu J, Ye L, et al.
Theranostics (2023) 1311: 3872-3896. 311 011AT647N ICC, FACS; tested species: human
Cat. No.: 311 011AT647N
Amount: 100 µg
Price: $470.00
Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes.
Gao Y, Su L, Wei Y, Tan S, Hu Z, Tao Z, Kovalik JP, Soong TW, Zhang J, Pu J, Ye L, et al.
Theranostics (2023) 1311: 3872-3896. 311 011AT647N ICC, FACS; tested species: human
Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes.
Gao Y, Su L, Wei Y, Tan S, Hu Z, Tao Z, Kovalik JP, Soong TW, Zhang J, Pu J, Ye L, et al.
Theranostics (2023) 1311: 3872-3896. 311 011AT647N ICC, FACS; tested species: human
IHC-P
Background

During cardiogenesis two major isoforms of myosin light chain 2 are co-expressed in a tightly regulated manner. MLC-2A is only present in the atrium while MLC-2V is exclusively expressed in the ventricle. Knock out studies revealed that the 2A isoform cannot substitute for the 2V variant in the ventricular chamber.
Recently it has been demonstrated that embryonic and adult stem cells can be differentiated into cardiomyocytes which may generate suitable replacements for damaged heart tissue in the future.
This monoclonal antibody is a useful tool to distinguish between ventricle and atrium specific cardiomyocytes.
Other products for this target